ADC Theatre cancellation notice: Please note that due to unforseen circumstances Cambridge Footlights 'benefit' performance of 'Non-Sexual Kissing', which was due to take place at Kilburn's Tricycle Theatre on Sunday 21 September, has had to be cancelled. 'Non-Sexual Kissing' can still be seen however at the ADC Theatre from Oct 7th - 11th at 11pm.
What do a computer programmer, a lab technician and a sociologist all have in common? They have all attended courses in genetics at the Institute of Continuing Education (ICE). Now the Institute has expanded its genetics course to a two-year Certificate Programme which starts for the first time this Autumn.
Research by scientists from the Departments of Pathology and Obstetrics and Gynaecology sheds new light on the treatment of endometriosis. The study successfully demonstrated in the laboratory that drugs which disrupt blood vessel development could be an alternative method of treatment for the disease.
A group of Cambridge University students will be bringing their own brand of fun science to seaside resorts over the next two weeks. Meanwhile back at the University staff from the Cavendish Laboratory will be offering tours of the Observatory as part of National Astronomy Week.
If you are holding a conditional offer of a place at a University of Cambridge College, and have met or exceeded all the conditions in your offer and have the grades required, congratulations! You don’t need to do anything. Your College will already have been told your A-level results, and your place is automatically confirmed. You will receive a letter from the College and from UCAS within a few days. Please do not phone the College at this busy time.
A patent application based on pioneering research at the University of Cambridge has generated an exclusive licence agreement between Cancer Research Technology Limited (CRT) and Alnylam Pharmaceuticals Inc. The research into gene expression in mammals was undertaken by Dr Magdalena Zernicka-Goetz and colleagues Dr Florence Wianny, Professors David Glover and Martin Evans at the University, with funding from Cancer Research UK.